BioNTech SE (BNTX) Current Deferred Tax Assets (2019 - 2022)

BioNTech SE has disclosed Current Deferred Tax Assets across 4 years of filings, most recently posting $73.6 million for Q3 2022.

• Current Deferred Tax Assets for Q3 2022 came in at $73.6 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2022 was $73.6 million (changed N/A YoY), and the FY2021 annual result was $55.5 million, up 66.19% from the prior year.
• Current Deferred Tax Assets came in at $73.6 million for Q3 2022 at BioNTech SE, down from $80.7 million in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $90.6 million in Q1 2022 to a low of $6.5 million in Q4 2019.
• The 4-year median for Current Deferred Tax Assets is $55.5 million (2021), against an average of $54.0 million.
• Across the five-year window, Current Deferred Tax Assets surged 414.51% in 2020 and soared 66.19% in 2021, its largest moves.
• BioNTech SE's Current Deferred Tax Assets stood at $6.5 million in 2019, then soared by 414.51% to $33.4 million in 2020, then jumped by 66.19% to $55.5 million in 2021, then soared by 32.66% to $73.6 million in 2022.
• The last three Current Deferred Tax Assets figures came in at $73.6 million (Q3 2022), $80.7 million (Q2 2022), and $90.6 million (Q1 2022), per Business Quant data.